Cardiac Implantable Electronic Device Market

The rising incidence of cardiovascular diseases such as cardiac arrhythmia, ischemic heart disease, and hypertension is expected to boost the growth of market.

SEATTLE, WASHINGTON, UNITED STATES, December 8, 2021 /EINPresswire.com/ -- Another factual information on the "Cardiac Implantable Electronic Device Market" has as of late added by CMI to its storehouse. This research report offers an inside and out examination of various perspectives, for example, market patterns, pieces of the overall industry, drivers, restrictions, opportunities. It gives an investigative view to settle on further choices in organizations. It covers comprehensive instructive information of various key players working over the globe.

Request PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/3949

Drivers:

The rising incidence of cardiovascular diseases such as cardiac arrhythmia, ischemic heart disease, and hypertension is expected to boost the growth of the cardiac implantable electronic device market. For instance, According to a 2015 WHO report, cardiovascular diseases were the leading cause of death globally in 2015, accounting for 17.7 million deaths.

Moreover, technological advancements in cardiac management devices are also expected to fuel the growth of the market. For instance, the use of advanced cardiac pacemakers, such as pacemakers with longer battery life and MRI safe-pacemakers, can help patients with bradycardia delay the progression of persistent atrial fibrillation (AF). These developments are gaining traction, and demand for cardiac rhythm management devices is expected to rise in the near future. For example, the US Food and Drug Administration (FDA) approved Abbott's MR-conditional labeling for the Assurity MRI pacemaker and the Tendril MRI pacing lead in February 2017.

Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/3949

Major players are adopting strategies such as mergers and acquisitions to expand their product portfolio. For instance, MicroPort Scientific Corporation and LivaNova PLC signed a binding Letter of Intent (LOI) in November 2017 to sell LivaNova's Cardiac Rhythm Management (CRM) enterprise franchise to MicroPort for US$ 190 million. Pacemakers, high-voltage defibrillators, and cardiac resynchronization treatment devices are all part of the LivaNova PLC Company's CRM product portfolio.

Covid-19 Impact:

The global COVID-19 pandemic is having a negative effect on the cardiac implantable electronic device market. Many hospitals have classified hospital outpatient-based cardiac care departments as non-essential, making it difficult for patients with cardiac disease to access care.

Among types, the implantable pacemakers segment is expected to hold a major revenue share in 2027. Advanced technologies like wireless and automated pacemakers, as well as tracking pacemakers, are gaining traction among healthcare providers. For instance, in 2016, in the United States, Biotronik debuted CardioMessenger Smart, a portable tracking device. Patients with pacemakers, implantable cardioverter defibrillators (ICDs), and insertable cardiac monitors (ICMs) will use this system, which is about the size of a modern smartphone, to communicate with their doctors remotely. This CardioMessenger Smart helps doctors detect and avoid potential cardiac events by ensuring patient compliance and consistent data transmission.

Key Takeaways:

The rising incidence of cardiovascular diseases such as cardiac arrhythmia, ischemic heart disease, and hypertension is expected to boost the growth of the cardiac implantable electronic device market.

The cardiac implantable electronic device market is expected to exhibit a CAGR of 7.7% over the forecast period (2020-2027), owing to the rising incidence of cardiac disorders

Major players operating in the cardiac implantable electronic device market include Medtronic plc. Braile Biomédica, Abbott Laboratories, Sorin Group, Biotronik, Boston Scientific Corporation, Shree Pacetronix Ltd., CCC Medical Devices, Cook Group Incorporated, Osypka Medical GmbH, Galix Biomedical Instrumentation Inc., and Oscor Inc.

Reasons to Purchase this Report

• Current and future of Cardiac Implantable Electronic Device Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Buy This Research Study Report Here @ https://www.coherentmarketinsights.com/insight/buy-now/3949

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Cardiac Implantable Electronic Device Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Cardiac Implantable Electronic Device Industry Impact

Chapter 2 Cardiac Implantable Electronic Device Competition by Types, Applications, and Top Regions and Countries
2.1 Cardiac Implantable Electronic Device (Volume and Value) by Type
2.3 Cardiac Implantable Electronic Device (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Cardiac Implantable Electronic Device Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Cardiac Implantable Electronic Device Market Analysis
Chapter 6 East Asia Cardiac Implantable Electronic Device Market Analysis
Chapter 7 Europe Cardiac Implantable Electronic Device Market Analysis
Chapter 8 South Asia Cardiac Implantable Electronic Device Market Analysis
Chapter 9 Southeast Asia Cardiac Implantable Electronic Device Market Analysis
Chapter 10 Middle East Cardiac Implantable Electronic Device Market Analysis
Chapter 11 Africa Cardiac Implantable Electronic Device Market Analysis
Chapter 12 Oceania Cardiac Implantable Electronic Device Market Analysis
Chapter 13 South America Cardiac Implantable Electronic Device Market Analysis
Chapter 14 Company Profiles and Key Figures in Cardiac Implantable Electronic Device Business
Chapter 15 Cardiac Implantable Electronic Device Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology

Other Reports:

Lung Cancer Diagnostic and Screening Market - https://www.businesswire.com/news/home/20210506005752/en

Agitation in Delirium Management Market - https://www.businesswire.com/news/home/20210428005509/en

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Mr. Shah
Coherent Market Insights Pvt. Ltd.
+ +91 88494 80752
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other